Table 2.
Target virus | Culture positive no. (%) | RV16 assay positive no. (%) | RV15 assay positive no. (%) | Statistical differencea |
---|---|---|---|---|
INF A | 48 (63.2%) | 76 (100%) | 71 (93.4%) | NS |
INF B | 27 (69.2%) | 35 (89.7%) | 31 (79.5%) | NS |
RSV | 101 (62.7%) | 158 (98.1%) | 151 (93.4%) | NS |
ADV | 14 (23.0%) | 60 (98.4%) | 32 (52.4%) | <0.05 |
PIV | 11 (45.8%) | 24 (100%) | 18 (75%) | <0.05 |
HRV | – | 125 (100%) | 101 (80.8%) | <0.05 |
OC43 | – | 22 (91.7%) | 24 (100%) | NS |
229E/NL | – | 27 (100%) | 15 (55.6%) | <0.05 |
HBoV | – | 21 (100%) | 13 (61.9%) | <0.05 |
MPV | – | 46 (92.0%) | 44 (88.0%) | NS |
HEV | – | 10 (90.9%) | 10 (90.9%) | NS |
Total positive | 201 (31.8%) | 604 (97.4%) | 510 (82.3%) | NS |
Between RV16 and RV15 by McNemar's test.